4.7 Article

A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Respiratory System

Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series

Felix J. F. Herth et al.

Summary: This study retrospectively evaluated the clinical courses of 12 COVID-19 patients who received IVIG treatment, showing that IVIG may improve the clinical state of patients with moderate to severe COVID-19 infection. Despite high illness severity scores, all patients survived hospital discharge.

RESPIRATION (2021)

Editorial Material Respiratory System

Intravenous Immunoglobulin for the Treatment of COVID-19: A Promising Tool

Vasilios Tzilas et al.

RESPIRATION (2021)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Respiratory System

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

Wei-jie Guan et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Review Allergy

Update on the use of immunoglobulin in human disease: A review of evidence

Elena E. Perez et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Article Medicine, General & Internal

Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection

Yaseen M. Arabi et al.

ANNALS OF INTERNAL MEDICINE (2014)

Article Immunology

Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients

JT Wang et al.

EMERGING INFECTIOUS DISEASES (2004)